Skip to main content
SpringerLink
Log in

Expression of Multidrug Resistance-associated Protein (MRP) in Human Gliomas

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Drug resistance is a major clinical problem in the chemotherapy of human gliomas. The multidrug resistance-associated protein (MRP), a membrane transporter related to non-P-glycoprotein multidrug resistance, is overexpressed in some drug-selected cancer cell lines. To investigate whether MRP is involved in the intrinsic drug resistance of human gliomas, surgical specimens of 20 gliomas (11 glioblastomas, 6 anaplastic astrocytomas, and 3 astrocytomas), 3 normal brain specimens, and 4 glioma cell lines (U87MG, U251MG, U373MG, and T98G) were analyzed. The expression of MRP was studied by RT-PCR and immunohistochemistry in the surgical specimens. The MRP expression levels in the cell lines were assessed by the quantitative RT-PCR and Western blot analyses. Sensitivity to adriamycin (ADM), etoposide (VP-16), cisplatin (CDDP), and 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU), were determined by MTT assay, and antisense treatment was evaluated in the cell lines. The expression of MRP was detected in 9 of 11 glioblastomas and 3 of 6 anaplastic astrocytomas. The quantitative analyses of the cell lines revealed that the MRP mRNA and protein levels were increased 4.5-fold in the T98G cells as compared to U87MG. T98G cells showed the highest resistance to all drugs. Western blot analysis revealed that treatment with the antisense oligonucleotide reduced the level of MRP expression to 25% of the sense oligonucleotide treatment in T98G cells. The sensitivity to ADM, VP-16 and CDDP was significantly increased in the antisense-treated cells as compared with the sense-treated cells. These results suggest that the MRP expression may be related to the intrinsic multidrug resistance in human gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Levin VA, Hoffman WF, Pischer TL, Seager ML, Boldrey EB, Wilson CB: BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors. Cancer Treat Rep 62: 2071-2076, 1978

    Google Scholar 

  2. Juliano RL, Ling V: A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455: 152-162, 1976

    Google Scholar 

  3. Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Robinson IB: Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47: 381-389, 1986

    Google Scholar 

  4. Matsumoto T, Tani E, Kaba K, Shindo H, Miyaji K: Expression of P-glycoprotein in human glioma cell lines and surgical glioma specimens. J Neurosurg 74: 460-466, 1991

    Google Scholar 

  5. Toth K, Vaughan MM, Peress NS, Slocum HK, Rustum YM: mdr1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. Am J Pathol 149: 853-858, 1996

    Google Scholar 

  6. Nitta H, Hayashi Y, Okada Y, Tachibana O, Mouri M, Yamashima T, Yamashita J: Metallothionein in glioma. In: Brain Tumor Research and Therapy. 1st edn, Nagai M (ed), Springer-Verlag, Tokyo, 1996, pp 61-66

    Google Scholar 

  7. Hara A, Yamada H, Sakai N, Hirayama H, Tanaka T, Mori H: Immunohistochemical demonstration of the placental form of glutathione S-transferase, a detoxifying enzyme in human gliomas. Cancer 66: 2563-2568, 1990

    Google Scholar 

  8. Mousseau M, Chauvin C, Nissou MF, Chaffanet M, Plantaz D, Pasquier B, Schaerer R, Benabid A: A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumors. Eur J Cancer 29A: 153-159, 1993

    Google Scholar 

  9. Nagane M, Asai A, Shibui S, Nomura K, Matsutani M, Kuchino Y: Expression of O-6-methylguanine-DNA methyl-transferase and chloroethylnitrosourea resistance of human brain tumors. Jpn J Clin Oncol 22: 143-149, 1992

    Google Scholar 

  10. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992

    Google Scholar 

  11. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC, Deeley RG: Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54: 357-361, 1994

    Google Scholar 

  12. Flens MJ, Zaman GJ, van dVP, Izquierdo MA, Schroeijers AB, Scheffer GL, van dGP, de HM, Meijer CJ, Scheper RJ: Tissue distribution of the multidrug resistance protein. Am J Pathol 148: 1237-1247, 1996

    Google Scholar 

  13. Nooter K, Westerman AM, Flens MJ, Zaman GJR, Scheper RJ, van Wingerden KE, Burger H, Oostrum R, Boersma T, Sonneveld P, Gratama JW, Kok T, Eggermont AMM, Bosman FT, Stoter G: Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin Cancer Res 1: 1301-1310, 1995

    Google Scholar 

  14. Nooter K, de la Riviere GB, Look MP, van Wingerden KE, Henzen-Lodmans SC, Scheper RJ, Flens MJ, Klijn JGM, Stoter G, Foekens JA: The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer. Br J Cancer 76: 486-493, 1997

    Google Scholar 

  15. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumors of the Central Nervous System, 2nd edn. Springer-Verlag, Berlin, 1993, pp 11-30

    Google Scholar 

  16. Schadendorf D, Makki A, Stahr C, van DA, Wanner R, Scheffer GL, Flens MJ, Scheper R, Henz BM: Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol 147: 1545-1552, 1995

    Google Scholar 

  17. Maier JAM, Voulalas P, Roeder D, Maciag T: Extension of life-span of human endothelial cells by an interleukin-1α antisense oligomer. Science 249: 1570-1574, 1990

    Google Scholar 

  18. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987

    Google Scholar 

  19. Flens MJ, Izquierdo MA, Scheffer GL, Fritz JM, Meijer CJ, Scheper RJ, Zaman GJ: Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res 54: 4557-4563, 1994

    Google Scholar 

  20. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, Roninson IB: Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160-7164, 1990

    Google Scholar 

  21. Nakayama H, Yokoi H, Fujita J: Quantification of mRNA by non-radioactive RT-PCR and CCD imaging system. Nucleic Acid Res 20: 4939, 1992

    Google Scholar 

  22. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Method 65: 55-63, 1983

    Google Scholar 

  23. Stewart AJ, Canitrot Y, Baracchini E, Dean NM, Deeley RG, Cole SPC: Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides. Biochem Pharmacol 51: 461-469, 1996

    Google Scholar 

  24. Thierry AR, Rahman A, Dritschilo A: Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides. Biochem Biophys Res Commun 190: 952-960, 1993

    Google Scholar 

  25. Takano H, Kohno K, Ono M, Uchida Y, Kuwano M: Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells. Cancer Res 51: 3951-3957, 1991

    Google Scholar 

  26. Kelley SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS: Overexpression of metallothionein confers resistance to anticancer drugs. Science 241: 1813-1815, 1988

    Google Scholar 

  27. Black SM, Beggs JD, Hayes JD, Bartoszek A, Muramatsu M, Sakai M, Wolf CR: Expression of human glutathione S-transferases in Saccharomyces cerevisiae confers resistance to the anticancer drugs adriamycin and chlorambucil. Biochem J 268: 309-315, 1990

    Google Scholar 

  28. Taira K, Benkovic SJ: Evaluation of the importance of hydrophobic interactions in drug binding to dihydrofolate reductase. J Med Chem 31: 129-137, 1988

    Google Scholar 

  29. Pegg AE: Mammalian O-6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 50: 6119-6129, 1990

    Google Scholar 

  30. Ueda K, Clark DP, Chen CJ, Robinson IB, Gottesman MM, Pastan I: The human multidrug resistance (mdr1) gene. cDNA-cloning and transcription initiation. J Biol Chem 262: 505-508, 1987

    Google Scholar 

  31. Nooter K, Herweijer H: Multidrug resistance (mdr) genes in human cancer. Br J Cancer 63: 663-669, 1991

    Google Scholar 

  32. Cordon CC, O'Brien JP, Casals D, Rittman GL, Biedler JL, Melamed MR, Bertino JR: Multidrug-resistance gene (Pglycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86: 695-698, 1989

    Google Scholar 

  33. Abe T, Mori T, Wakabayashi Y, Nakagawa M, Cole SPC, Koike K, Kuwano M, Hori S: Expression of multidrug resistance protein in patients with glioma after chemotherapy. J Neuro-Oncol 40: 11-18, 1998

    Google Scholar 

  34. Krishnamachary N, Center MS: The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res 53: 3658-3661, 1993

    Google Scholar 

  35. Zaman GJ, Flens MJ, van Leusden MR, de Haas M, Mulder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ, Borst P: The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91: 8822-8826, 1994

    Google Scholar 

  36. Fillpits M, Suchomel RW, Dekan G, Stiglbauer W, Haider K, Depisch D, Pirker R: Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas. Br J Cancer 75: 208-212, 1997

    Google Scholar 

  37. Campling BG, Young LC, Bear KA, Lam YM, Deeley RG, Cole SPC, Gerlach JH: Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer. Clin Cancer Res 3: 115-122, 1997

    Google Scholar 

  38. Filipits M, Suchomel RW, Dekan G, Haider K, Valdimarsson G, Depisch D, Pirker R: MRP and MDR1 gene expression in primary breast carcinomas. Clin Cancer Res 2: 1231-1237, 1996

    Google Scholar 

  39. Chan HSL, Lu Y, Grogan TM, Haddad G, Hipfner DR, Cole SPC, Deeley RG, Ling V, Gallie BL: Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of p-glycoprotein. Cancer Res 57: 2325-2330, 1997

    Google Scholar 

  40. Kuss BJ, Deeley RG, Cole SPC, Willman CL, Kopecky KJ, Wolman SR, Eyre HJ, Lane SA, Nancarrow JK, Whitmore SA, Callen DF: Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications. Lancet 343: 1531-1534, 1994

    Google Scholar 

  41. Zaman GJR, Versantvoort CH, Smit JJ, Eijdems EW, de HM, Smith AJ, Broxterman HJ, Mulder NH, de VE, Baas F, Borst P: Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 53: 1747-1750, 1993

    Google Scholar 

  42. Abe T, Hasegawa S, Taniguchi K, Yokomizo A, Kuwano T, Ono M, Mori T, Hori S, Kohno K, Kuwano M: Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells. Int J Cancer 58: 860-864, 1994

    Google Scholar 

  43. Kruh GD, Chan A, Myers K, Gaughan K, Miki T, Aaronson SA: Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene. Cancer Res 54: 1649-1652, 1994

    Google Scholar 

  44. Leier I, Jedlitschky G, Buchholz U, Cole SPC, Deeley RG, Keppler D: The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 269: 27 807-27 810, 1994

    Google Scholar 

  45. Muller M, Meijer C, Zaman GJ, Borst P, Scheper RJ, Mulder NH, de VE, Jansen PL: Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 91: 13 033-13 037, 1994

    Google Scholar 

  46. Priebe W, Krawczyk M, Kuo MT, Yamane Y, Savaraj N, Ishikawa T: Doxrubicin-and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump. Biochem Biophys Res Commun 247: 859-863, 1998

    Google Scholar 

  47. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, Keppler D: Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 56: 988-994, 1996.

    Google Scholar 

  48. Ishikawa T, Bao JJ, Yamane Y, Akimaru K, Frindrich K, Wright CD, Kuo MT: Coordinated induction of MRP/GSX pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells. J Biol Chem 271: 14981-14988, 1996

    Google Scholar 

  49. Matsukura M, Shinozuka K, Zon G, Mitsuya H, Reitz M, Cohen JS, Broder S: Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc Natl Acad Sci USA 84: 7706-7710, 1987

    Google Scholar 

  50. Gao Z, Fields JZ, Boman BM: Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells. Anticancer Res 17: 3073-3076, 1997

    Google Scholar 

  51. Almquist KC, Loe DW, Hipfner DR, Mackie JE, Cole SPC, Deeley RG: Characterization of the Mr 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell. Cancer Res 55: 102-110, 1995

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Kanazawa University School of Medicine, Kanazawa, Japan

    Masanao Mohri, Hisashi Nitta & Junkoh Yamashita

Authors
  1. Masanao Mohri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hisashi Nitta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Junkoh Yamashita
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mohri, M., Nitta, H. & Yamashita, J. Expression of Multidrug Resistance-associated Protein (MRP) in Human Gliomas. J Neurooncol 49, 105–115 (2000). https://doi.org/10.1023/A:1026528926482

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026528926482

Search

Navigation